FDA Looks To Expand Drug GMPs Further Up The Pharmaceutical Supply Chain
This article was originally published in The Tan Sheet
FDA looks to assert its regulatory authority further up the pharmaceutical supply chain with new good manufacturing practice requirements and an expansive interpretation of International Conference on Harmonization guidelines
You may also be interested in...
The Senate's food safety reform bill relieves the dietary supplement industry's biggest concern about the legislation by excluding supplement firms from duplicative manufacturing regulations
The sudden abundance of formerly scarce raw ingredients for dietary supplements may signal economically motivated adulteration
FDA plans to hold a public workshop this spring to begin the task of combating profit-motivated adulteration of regulated products